Showing results (371-380 of 414) with videos related to

Sort By:
Pageof 42
Gynecologic Oncology|April 4, 2021
Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center studyAntonio Raffone, Ursula Catena, Antonio Travaglino, et al.
International Journal of Biological Macromolecules|July 23, 2025
Disruption of c-Myc/Max heterodimerization induced by a novel anticancer agent endowed with 1,3-diphenylurea moiety: an in silico, chemoproteomics-based, and in vitro combined approachErica Gazzillo, Lucia Capasso, Francesca Scala, et al.
Biomed Research International|October 7, 2022
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic ReviewPierluigi Giampaolino, Valeria Cafasso, Dominga Boccia, et al.
Molecules (Basel, Switzerland)|January 10, 2026
Potential Nutraceutical Properties of Vicia faba L: LC-ESI-HR-MS/MS-Based Profiling of Ancient Faba Bean Varieties and Their Biological ActivityFrancesca Fantasma, Gilda D'Urso, Alessandra Capuano, et al.
Biochemical Pharmacology|March 6, 2019
Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: A promising pharmacological strategy for anti-inflammatory therapyJana Gerstmeier, Christian Kretzer, Simone Di Micco, et al.
European Journal of Medicinal Chemistry|July 15, 2026
Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ERα inhibitors with in vitro activity in breast cancer modelsEster Colarusso, Simona De Vita, Eleonora Boccia, et al.
Archiv Der Pharmazie|December 18, 2024
5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidatesEster Colarusso, Gianluigi Lauro, Marianna Potenza, et al.
Pharmacological Research|November 22, 2017
Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's diseaseFrancesco Maione, Marialuisa Piccolo, Simona De Vita, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 9, 2025
Unveiling New Triazoloquinoxaline-Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9Martina Pierri, Guglielmo Bove, Erica Gazzillo, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis InhibitorsMarianna Potenza, Assunta Giordano, Maria G Chini, et al.
Pageof 42